Corvus Pharmaceuticals, Inc. (CRVS) Operating Income (Loss) USD 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Corvus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$6.25 M, a 4.88% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$23.1 M, a 27.2% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$23.4 M, a 28.1% increase from 2022.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$32.6 M, a 15.7% increase from 2021.
  • Corvus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$38.6 M, a 11.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$23.1 M -$6.25 M +$321 K +4.88% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$23.4 M -$5.65 M +$15 K +0.27% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$23.4 M -$5.56 M +$6.91 M +55.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$30.3 M -$5.62 M +$1.39 M +19.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$31.7 M -$6.57 M +$839 K +11.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$32.6 M -$5.67 M +$1.14 M +16.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$33.7 M -$12.5 M -$3.43 M -37.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$30.3 M -$7.01 M +$4.28 M +37.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$34.6 M -$7.41 M +$4.07 M +35.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$38.6 M -$6.81 M +$3.07 M +31.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-19
Q3 2021 -$41.7 M -$9.05 M +$798 K +8.11% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$42.5 M -$11.3 M -$523 K -4.86% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$42 M -$11.5 M +$1.79 M +13.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$43.8 M -$9.88 M +$1.56 M +13.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-28
Q3 2020 -$45.3 M -$9.85 M +$1.67 M +14.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$47 M -$10.8 M +$2.83 M +20.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 -$49.8 M -$13.3 M -$964 K -7.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 -$48.9 M -$11.4 M -$269 K -2.41% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$48.6 M -$11.5 M -$364 K -3.27% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$48.2 M -$13.6 M -$1.34 M -10.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 -$46.9 M -$12.3 M +$2.34 M +16% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 -$49.2 M -$11.2 M +$1.02 M +8.35% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 -$50.2 M -$11.1 M +$1.8 M +13.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$52 M -$12.3 M +$2.92 M +19.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$55 M -$14.6 M +$1.57 M +9.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$56.5 M -$12.2 M -$940 K -8.36% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-09
Q3 2017 -$55.6 M -$12.9 M -$2.47 M -23.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$53.1 M -$15.2 M -$6.35 M -71.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$46.8 M -$16.2 M -$9.79 M -152% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$37 M -$11.2 M -$5.15 M -84.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$31.8 M -$10.5 M -$7.36 M -236% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$24.5 M -$8.83 M -$6.49 M -278% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$18 M -$6.43 M -$4.21 M -190% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$13.8 M -$6.1 M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$3.12 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$2.33 M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$2.21 M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.